三個皮匠報告
政策庫
new
付費
搜索

利拉魯肽競爭格局-行業數據

利拉魯肽競爭格局
利拉魯肽競爭格局
GLP-1 利拉魯肽注射液已獲批上市，口服降糖藥恩格列凈片上市申請已獲得受理，預計于 2023 年底可獲批上市，收獲實質性成果。國內利拉魯肽目前僅有諾和諾德和華東制藥兩家有上市產品，市場競爭較小。
競爭格局 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?2KB 圖片尺寸：2310*566
同報告圖片
 / 39
利拉魯肽競爭格局_第1頁
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
利拉魯肽競爭格局_第2頁
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
利拉魯肽競爭格局_第3頁
利拉魯肽競爭格局_第4頁
fCDliIbnsbsgICB8IOeUt+aAp+WNoOavlCB8IOWls+aAp+WNoOavlCB8CnwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwKfCDotoXph43mr5TkvosgfCA0MS4xMCUgfCAyNy43MCUgfAp8IOiCpeiDluavlOS+iyB8IDE4LjIwJSB8IDkuNDAlICB8
利拉魯肽競爭格局_第5頁
5Lul5LiL5piv5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yaCgp8IOeWvueXhSAgICAgICB8IOWNoOavlCAgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLXwKfCDohILogqrogp0gICAgIHwgMzMlICB8Cnwg57OW5bC/55eF5YmN5pyfIHwgMjYlICB8Cnwg6KGA6ISC5byC5bi4ICAgfCAyNCUgIHwKfCDpq5jooYDljosgICAgIHwgMTclICB8CgrotYTmlpnmnaXmupDvvJrjgIrkuK3lm73ogqXog5bmgqPnl4Xnjoflj4rnm7jlhbPlubblj5Hnl4fvvJoxNTgw5LiH5oiQ5bm05Lq655qE5qiq5pat6Z2i55yf5a6e5LiW55WM56CU56m244CL77yM5L2c6ICF77yaS2FuZyBDaGVu
利拉魯肽競爭格局_第6頁
利拉魯肽競爭格局_第7頁
利拉魯肽競爭格局_第8頁
55Sx5LqO5oKo5o+Q5L6b55qE5Zu+54mH5YaF5a656L6D5Li65qih57OK77yM5peg5rOV6K+G5Yir5YW35L2T55qE5paH5a2X5YaF5a6544CC6K+35o+Q5L6b5pu05riF5pmw55qE5Zu+54mH5oiW5paH5a2X5L+h5oGv77yM5Lul5L6/5oiR5biu5Yqp5oKo5o+Q5Y+W5pWw5o2u5bm255Sf5oiQ6KGo5qC844CC
利拉魯肽競爭格局_第9頁
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
利拉魯肽競爭格局_第10頁
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
利拉魯肽競爭格局_第11頁
利拉魯肽競爭格局_第12頁
利拉魯肽競爭格局_第13頁
利拉魯肽競爭格局_第14頁
利拉魯肽競爭格局_第15頁
利拉魯肽競爭格局_第16頁
利拉魯肽競爭格局_第17頁
5qC55o2u5Zu+54mH5Lit55qE5p+x54q25Zu+77yM5Y+v5Lul5o+Q5Y+W5Lul5LiL5pWw5o2u77yaCgp8IOe+pOS9kyAgIHwg5Y2g5q+UICB8CnwtLS0tLS0tLXwtLS0tLS0tfAp8IOaIkOS6uuWxheawkSB8IDE1JSAgIHwKfCDmiJDkurrnlLfmgKcgfCAyNSUgICB8Cnwg5oiQ5Lq65aWz5oCnIHwgNSUgICAgfAoK6LWE5paZ5p2l5rqQ77ya44CK55eb6aOO6K+K55aX6KeE6IyD77yIMjAyM+W5tO+8ieOAi++8jOS9nOiAhe+8muS4reWNjuWMu+WtpuS8mumjjua5v+eXheWtpuWIhuS8mu+8jOawkeeUn+ivgeWIuOeglOeptumZouOAgg==
利拉魯肽競爭格局_第18頁
利拉魯肽競爭格局_第19頁
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
利拉魯肽競爭格局_第20頁
利拉魯肽競爭格局_第21頁
利拉魯肽競爭格局_第22頁
利拉魯肽競爭格局_第23頁
利拉魯肽競爭格局_第24頁
利拉魯肽競爭格局_第25頁
利拉魯肽競爭格局_第26頁
利拉魯肽競爭格局_第27頁
利拉魯肽競爭格局_第28頁
利拉魯肽競爭格局_第29頁
利拉魯肽競爭格局_第30頁
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
利拉魯肽競爭格局_第31頁
fCDlnLDljLogICAgICAgfCDljaDmr5QgIHwKfC0tLS0tLS0tLS0tLXwtLS0tLS18Cnwg5YyX576O5ZKM5Yqg5YuS5q+U5Zyw5Yy6IHwgOCUgICB8Cnwg5qyn5rSyICAgICAgIHwgOSUgICB8Cnwg6KW/5aSq5bmz5rSL5Zyw5Yy6ICAgfCAzMyUgIHwKfCDljZfnvo7lnLDljLogICAgIHwgNiUgICB8Cnwg6Z2e5rSyICAgICAgIHwgNyUgICB8Cnwg5Lit5Lic5ZKM5YyX6Z2e5Zyw5Yy6IHwgMTclICB8Cnwg5Lic5Y2X5LqaICAgICAgfCAyMCUgIHwKCui1hOaWmeadpea6kDogSURGMjAyMeW5tOesrOWNgeeJiOOAiuWFqOeQg+ezluWwv+eXheamguiniOOAiywg5rCR55Sf6K+B5Yi456CU56m26Zmi
利拉魯肽競爭格局_第32頁
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
利拉魯肽競爭格局_第33頁
利拉魯肽競爭格局_第34頁
利拉魯肽競爭格局_第35頁
利拉魯肽競爭格局_第36頁
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
利拉魯肽競爭格局_第37頁
利拉魯肽競爭格局_第38頁
利拉魯肽競爭格局_第39頁
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
利拉魯肽競爭格局_第40頁
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
所屬報告： 通化東寶-公司深度研究：創新產品加速企業轉型海外商業化蓄勢待發-231208（32頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站